Celebrations as NHS England agrees deal for Vertex’ cystic fibrosis triple
NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after the EMA’s human medicines committee recommended approval of the drug. The deal means that CF patients in England will be among the first in Europe to access Kaftrio...
pharmaphorum.com